PAKOLA STEVE (CIK 1700659) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-06). Recent activity: Sell RGNX (2,161 shares), Buy RGNX (2,161 shares), Sell RGNX (36,725 shares), Sell RGNX (19,608 shares), Buy RGNX (36,725 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | Sell | 2,161 | $29,476 |
| 2026-07-06 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | Buy | 2,161 | $16,985 |
| 2026-07-01 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | Sell | 36,725 | $472,284 |
| 2026-07-01 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | Sell | 19,608 | $216,472 |
| 2026-07-01 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | Buy | 36,725 | $288,658 |
| 2026-05-13 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | Sell | 15,309 | $168,705 |
| 2026-03-12 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | Sell | 5,124 | $53,033 |
| 2026-02-03 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | Sell | 5,267 | $58,780 |
| 2026-01-08 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | Buy | 65,847 | $0 |
| 2026-01-06 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | Sell | 18,247 | $262,757 |
| 2025-04-04 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | Sell | 5,263 | $42,472 |
Source: SEC Form 4 filings · as of 2026-07-06